3.4501
Immix Biopharma Inc (IMMX) 最新ニュース
Immix Biopharma to present NXC-201 trial data for AL amyloidosis at ASH - Investing.com Australia
Can trapped investors hope for a rebound in Immix Biopharma Inc.2025 Momentum Check & Fast Gain Stock Tips - newser.com
How Immix Biopharma Inc. stock valuations compare to rivalsWeekly Trend Summary & Consistent Growth Equity Picks - newser.com
Why Immix Biopharma Inc. stock appeals to dividend seekersJuly 2025 Decliners & High Return Stock Watch Alerts - newser.com
How rising interest rates impact Immix Biopharma Inc. stock2025 Top Gainers & Technical Pattern Based Signals - newser.com
Immix Biopharma : Presentation (IMMX Corporate presentation November 2025) - MarketScreener
What analysts say about Immix Biopharma Inc stockTechnical Resistance Breaks & Affordable Portfolio Growth - earlytimes.in
How to manage a losing position in Immix Biopharma Inc.Trade Exit Summary & Capital Efficient Trading Techniques - newser.com
Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025 - Investing News Network
Immix Biopharma (IMMX) ASH 2025 oral to feature NEXICART-2 first 20-patient data on Dec 7 - Stock Titan
How Immix Biopharma Inc. stock reacts to bond yieldsGap Up & Free Expert Approved Momentum Trade Ideas - newser.com
Immix Biopharma Inc (IMMX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com
Immix Biopharma Inc. stock volume spike explainedJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
What the charts say about Immix Biopharma Inc. today2025 Analyst Calls & Safe Entry Point Identification - newser.com
Will Immix Biopharma Inc. stock sustain high P E ratiosEarnings Miss & Daily Entry Point Alerts - newser.com
Immix Biopharma Inc. stock trendline breakdownTrade Analysis Report & Daily Volume Surge Signals - newser.com
Comparing Immix Biopharma Inc. in custom built stock radarsQuarterly Portfolio Report & Reliable Breakout Forecasts - newser.com
Risk adjusted return profile for Immix Biopharma Inc. analyzedMarket Performance Recap & Risk Controlled Stock Alerts - newser.com
Is Immix Biopharma Inc. stock a smart buy before Fed meeting2025 Market Outlook & Daily Stock Momentum Reports - newser.com
Is Immix Biopharma Inc. still worth holding after the dip2025 Volume Leaders & Technical Confirmation Trade Alerts - newser.com
Will Immix Biopharma Inc. see short term momentum2025 Major Catalysts & Capital Protection Trading Alerts - newser.com
Immix Biopharma (NASDAQ:IMMX) Trading Down 1.3%Time to Sell? - MarketBeat
Momentum divergence signals in Immix Biopharma Inc. chartJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Immix Biopharma’s NXC-201 CAR-T Study: A Potential Game-Changer for AL Amyloidosis - TipRanks
大文字化:
|
ボリューム (24 時間):